Product image of Moxogamma (Moxonidine) supplied by GNH India

Moxogamma

Active Ingredient:
Moxonidine
Origin:
EU

Moxogamma (Moxonidine)

Moxonidine, the active ingredient in Moxogamma, is a Imidazoline receptor agonist presented as an oral dosage form for oral use. It is used to lower elevated blood pressure in adult patients with hypertension.

GNH India supplies Moxogamma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Wörwag Pharma Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Moxonidine acts on central imidazoline I1 receptors to manage high‑blood‑pressure conditions.

  • Hypertension (essential): reduces systolic and diastolic pressure in patients with primary hypertension.
  • Elevated systolic pressure: helps achieve target systolic values when lifestyle measures are insufficient.
  • Elevated diastolic pressure: contributes to lowering diastolic readings as part of a comprehensive antihypertensive regimen.

How It Works

  • Moxonidine selectively stimulates central imidazoline I1 receptors, which diminishes sympathetic nervous system outflow. This reduction leads to decreased peripheral vascular resistance and lower cardiac output, ultimately producing a modest decline in arterial blood pressure without significant reflex tachycardia.

Side Effects

Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Dry mouth: sensation of oral dryness without obvious cause.
  • Fatigue: feeling unusually tired or low in energy.
  • Dizziness: light‑headedness, especially when standing quickly.
  • Headache: mild to moderate head pain.
  • Nausea: unsettled stomach with urge to vomit.
  • Constipation: reduced bowel movements or hard stools.

Serious or Rare Side Effects

  • Severe hypotension: markedly low blood pressure that may cause fainting.
  • Bradycardia: abnormally slow heart rate requiring medical attention.
  • Allergic reactions: rash, itching, swelling, or difficulty breathing.
  • Liver enzyme elevation: abnormal liver function tests detected in labs.
  • Cardiac arrhythmia: irregular heart rhythm that could be life‑threatening.

Precautions & Warnings

Before initiating therapy with Moxogamma, several safety considerations should be observed.

  • Blood pressure monitoring: regularly check to avoid excessive hypotension.
  • Renal impairment: adjust dose or monitor closely in patients with reduced kidney function.
  • Diabetes mellitus: watch for changes in glucose control as sympathetic modulation may affect insulin sensitivity.
  • Concomitant antihypertensives: be cautious when combined with other blood‑pressure‑lowering agents to prevent additive effects.
  • Discontinuation: avoid abrupt stopping; taper under medical supervision to reduce rebound hypertension.
  • Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Moxonidine can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

  • Other central antihypertensives (e.g., clonidine, guanfacine): may cause excessive fall in blood pressure.
  • Strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): can increase plasma levels of moxonidine.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive response.
  • Diuretics: can enhance electrolyte disturbances and volume depletion.
  • Beta‑blockers: may amplify bradycardia when used together.
  • Alcohol: can increase dizziness and hypotensive effects.

Frequently Asked Questions

Moxogamma contains the active ingredient moxonidine and is prescribed to lower elevated blood pressure in adults with hypertension. It works by reducing sympathetic nervous system activity, helping patients achieve target blood‑pressure levels as part of a broader treatment plan.

Moxonidine selectively activates central imidazoline I1 receptors, which dampens sympathetic outflow from the brain. This leads to reduced peripheral vascular resistance and modest decreases in cardiac output, resulting in a gradual decline in arterial blood pressure without causing a rapid heart‑rate increase.

The appropriate dose of Moxogamma is determined by the prescribing clinician based on the individual’s blood‑pressure readings, overall health status, and any concurrent medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for moxonidine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To request Moxogamma, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Moxogamma belongs to the imidazoline receptor agonist class, offering a modest blood‑pressure reduction with a lower incidence of reflex tachycardia compared with some centrally acting agents like clonidine. Its side‑effect profile is generally favorable, but choice of therapy depends on patient‑specific factors and physician judgment.

Moxogamma should be stored below 25 °C in a dry place, protected from moisture and direct sunlight. Keep the product in its original packaging until use, and ensure that tablets are not exposed to excessive heat or humidity to maintain potency.

Moxogamma is taken orally, usually once daily with or without food as directed by the prescriber. The tablet should be swallowed whole with a glass of water; it should not be crushed, chewed, or split unless specifically advised by a healthcare professional.

The most serious risks include severe hypotension, marked bradycardia, allergic reactions such as rash or swelling, and rare liver enzyme elevations. Patients should seek immediate medical attention if they experience fainting, rapid heartbeat, difficulty breathing, or signs of liver dysfunction.

Moxogamma is contraindicated in patients with known hypersensitivity to moxonidine or any excipients, and it should be avoided in individuals with severe hepatic impairment. Caution is also advised for patients with significant renal dysfunction, uncontrolled diabetes, or those taking other central antihypertensives without close monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Moxonidine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT